Today: 23 May 2026
Nvidia stock ends 2025 lower as Reuters flags China H200 orders and fresh TSMC talks
1 January 2026
2 mins read

Nvidia stock ends 2025 lower as Reuters flags China H200 orders and fresh TSMC talks

NEW YORK, January 1, 2026, 05:41 ET — Market closed

Nvidia shares ended Wednesday down about 0.5% at $186.50, after a Reuters report said the chip designer has approached Taiwan Semiconductor Manufacturing Co to ramp up output of its H200 artificial intelligence chips as Chinese demand accelerates.

The development matters because Nvidia’s supply has been tight, and any incremental demand from China could force trade-offs in who gets chips and when — a key input for revenue expectations and data-center buildout plans.

It also lands as investors reassess how fast the “AI trade” can keep running in 2026, with export rules and geopolitics again shaping who can buy the most powerful processors.

Reuters reported that Chinese technology companies have ordered more than 2 million H200 chips for delivery in 2026, far above Nvidia’s current inventory, with the chip priced at around $27,000 and additional production expected to start in the second quarter of 2026.

Nvidia told Reuters it was managing its supply chain and said licensed sales of H200 chips to authorized customers in China would not affect its ability to supply customers in the United States, the report said.

A separate Reuters report, citing the South China Morning Post, said ByteDance plans to spend about 100 billion yuan (about $14.3 billion) on Nvidia AI chips in 2026, contingent on approvals for H200 sales in China; Reuters said it could not independently verify the report.

Nvidia’s China opportunity comes with a policy catch: Beijing has yet to greenlight shipments of the H200 despite the Trump administration recently allowing exports of the chip to China, Reuters reported.

Nvidia was one of the market’s AI bellwethers in 2025, and the year’s final session ended with thin liquidity and profit-taking across major indexes, which fell modestly on Wednesday, according to Reuters. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters

Export controls stayed in focus across the semiconductor supply chain, with Reuters also reporting the U.S. granted TSMC an annual license to import American chipmaking tools into its China facility in Nanjing, replacing prior exemptions that expired on Dec. 31.

Ahead of the next major company-specific catalyst, Nvidia has scheduled multiple events at CES 2026 in Las Vegas, including an appearance by founder and CEO Jensen Huang, according to Nvidia’s CES page.

The company’s next earnings report is slated for February 25, 2026, according to Nvidia’s investor relations events calendar.

Macro data that can move rate expectations — and, by extension, high-growth tech valuations — also looms in early January, including the U.S. Employment Situation report for December 2025 on Jan. 9 and December CPI on Jan. 13, the Labor Department’s schedule shows.

Before the next session on Friday, investors will watch for any signs Beijing is moving toward approving H200 imports, and whether Nvidia’s push for additional TSMC capacity points to sustained order momentum rather than one-off year-start stocking.

Technically, the stock’s inability to hold above the $190 area in the last session leaves that level in focus, with the mid-$186 range acting as the first nearby support after Wednesday’s slide.

Stock Market Today

  • Morinaga Milk Industry Valuation Post Stock Split Highlights Potential Undervaluation
    May 23, 2026, 12:51 AM EDT. Morinaga Milk Industry (TSE:2264) approved a stock split effective July 1, 2026, boosting investor interest. The stock price gained 4.64% last week and 25.92% year-to-date, with a 1-year total shareholder return of 49.37%. Trading at a price-to-earnings (P/E) ratio of 17x, below the peer average of 33.6x but above the Japanese food industry average of 15.3x, the valuation reflects mixed signals. While the P/E suggests fair value relative to earnings, discounted cash flow (DCF) analysis estimates intrinsic value nearly double the current price, indicating potential undervaluation. Investors face a choice between P/E-based market pricing and deeper value suggested by future cash flow. The developments warrant close monitoring of growth prospects and governance changes at Morinaga Milk Industry.

Latest articles

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

23 May 2026
The Dow closed at a record 50,579.70 on Friday, while the S&P 500 notched its eighth straight weekly gain. After-hours trading saw SPY, QQQ, DIA, and IWM all move lower. U.S. markets will be closed Monday for Memorial Day. Investors await Thursday’s inflation data.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Stock Pauses as Nvidia Rally Cools Before Holiday

23 May 2026
IREN shares fell 2.1% to $56.83 Friday, ending a two-day rally but closing the week up 7.4%. The stock’s moves follow a $3.4 billion AI cloud deal with Nvidia and a $3 billion convertible note offering. March-quarter revenue dropped to $144.8 million, with a net loss of $247.8 million. U.S. markets close Monday for Memorial Day; trading resumes Tuesday.
AXT stock reaches record; investors weigh risk to rally

AXT stock reaches record; investors weigh risk to rally

23 May 2026
AXT shares jumped 16.37% to $140.83 on Friday, hitting a 52-week high and trading above all recent analyst targets. The surge followed strong demand for AI-linked optical networking hardware and a sharp rise in indium phosphide orders. First-quarter revenue climbed to $26.9 million, with gross margin turning positive. Management forecast Q2 profitability and a backlog over $100 million.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

HKEX stock ends 2025 slightly lower as Hong Kong IPO rush sets up 2026 catalysts
Next Story

HKEX stock ends 2025 slightly lower as Hong Kong IPO rush sets up 2026 catalysts

Go toTop